PREVENTION AND TREATMENT OF OSEA LOSS INDUCED BY INFLAMMATION AND / OR IMMUNOLOGICALLY MEASURED.

摘要

Use of a type 1 and type 2 11-a-HSD inhibitor or a pharmaceutically acceptable salt thereof, for the preparation of a pharmaceutical agent for the prevention and / or treatment of bone loss and / or cartilage induced by inflammation and / or immunologically mediated, in which said use is for the prevention and / or treatment of lytic bone metastases, arthritis, juvenile chronic arthritis and / or adjuvant arthritis, infectious diseases, HIV bone loss, dental loss, inflammation of bone marrow and / or synovial inflammation.